Format
Sort by

Send to

Choose Destination

Search results

Items: 12

1.

A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic disease.

Chan A, Morey A, Brown B, Hastrich D, Willsher P, Ingram D.

BMC Cancer. 2012 Nov 24;12:555. doi: 10.1186/1471-2407-12-555.

2.

Preoperative taxane-based chemotherapy in a standardized protocol for locally advanced breast cancer.

Chan A, Willsher PC, Hastrich DJ, Anderson J, Barham T, Latham B, Redfern A, VAN DER Schaaf A, Thomson J, Joseph D, Ingram D.

Asia Pac J Clin Oncol. 2012 Mar;8(1):62-70. doi: 10.1111/j.1743-7563.2011.01489.x.

PMID:
22369445
3.

The accuracy of intraoperative subareolar frozen section in nipple-sparing mastectomies.

Luo D, Ha J, Latham B, Ingram D, Connell T, Hastrich D, Yeow WC, Willsher P, Luo J.

Ochsner J. 2010 Fall;10(3):188-92.

4.

Prospective trial of intraoperative radiation treatment for breast cancer.

Joseph DJ, Bydder S, Jackson LR, Corica T, Hastrich DJ, Oliver DJ, Minchin DE, Haworth A, Saunders CM.

ANZ J Surg. 2004 Dec;74(12):1043-8.

PMID:
15574144
5.

Diagnosis of breast microcalcifications: a comparison of stereotactic FNA and core imprint cytology as adjuncts to core biopsy.

Newman MR, Frost FA, Sterrett GF, Bourke AG, Thompson RI, Hastrich DJ, Ingram DM.

Pathology. 2001 Nov;33(4):449-53.

PMID:
11827411
6.

Management of breast cancer in the elderly by complete local excision and tamoxifen alone.

Sader C, Ingram D, Hastrich D.

Aust N Z J Surg. 1999 Nov;69(11):790-3.

PMID:
10553967
7.

Comparison of radioligand assay and immunostaining for epidermal growth factor receptor in human breast cancer.

Hastrich DJ, Dunn JM, Nicholson S, Newcomb P, Farndon JR.

Br J Surg. 1994 Jun;81(6):853-5.

PMID:
8044601
8.

The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients.

Fox SB, Smith K, Hollyer J, Greenall M, Hastrich D, Harris AL.

Breast Cancer Res Treat. 1994 Jan;29(1):41-9.

PMID:
8018963
9.

Correlation between p53 mutations and antibody staining in breast carcinoma.

Dunn JM, Hastrich DJ, Newcomb P, Webb JC, Maitland NJ, Farndon JR.

Br J Surg. 1993 Nov;80(11):1410-2.

PMID:
8252351
10.

Epidermal growth factor receptor determination on tumour imprints.

Hastrich DJ, Dunn JM, Newcomb P, Hall P, Rooney N, Nicholson S, Farndon JR.

J Clin Pathol. 1993 Feb;46(2):166-8.

11.

Delay in the diagnosis of breast cancer: the effect of the introduction of fine needle aspiration cytology to a breast clinic.

Bates AT, Bates T, Hastrich DJ, Mackie ME, Padley SJ, Corfield NS, Padley NR.

Eur J Surg Oncol. 1992 Oct;18(5):433-7.

PMID:
1426292
12.

Diagnostic and therapeutic aspects of fine-wire localization biopsy for impalpable breast cancer.

Hastrich DJ, Dunn JM, Armstrong JS, Davies JD, Davies ZD, Webb AJ, Farndon JR.

Br J Surg. 1992 Oct;79(10):1038-41.

PMID:
1330196
Items per page

Supplemental Content

Loading ...
Support Center